Overview

The global pharmaceutical and life sciences industry faces significant opportunities for growth in the years ahead. The population is growing and aging, boosting the need for medicines in both the developed and developing world. The emergence of new diseases is creating new medical needs, whilst significant changes in the way that healthcare is delivered will provide opportunities for the provision of innovative new services. In order to capitalise on these opportunities, the industry must boost the productivity of its labs through new models and approaches to R&D, leverage the revenue and innovation potential of emerging markets, and increasingly tailor its sales and marketing strategies to new audiences and markets.

The FT Global Pharmaceutical and Biotechnology Conference is Europe’s pre-eminent industry event attended by leading executives, government decision makers, investors, analysts and other specialist providers. It provides a unique platform to present new perspectives,’ feel the pulse’ of the industry, and network with peers across the sector.

Topics to be addressed include:
 =>New Pricing Models for a New Era
 =>Tailoring Sales and Marketing Strategies to New Audiences and Markets
 =>Riding the Wave of Healthcare Consumerism
 =>Value and Performance in Pharma and Biotech - A Financial Perspective
 =>Harnessing the ‘Explosion of Science’-Transforming R&D
 =>Leveraging Emerging Markets for Innovation and Revenue Growth

Speakers include

Bob Go, Global Managing Director, Life Science and Health Care, Deloitte
David Brennan, Chief Executive Officer, AstraZeneca PLC
William M. Burns, Chief Executive Officer, Roche Pharmaceutical Division
Wayne Gattinella, President and CEO, WebMD
Stefano Pessina, Executive Chairman, Alliance Boots
Angus Russell, CEO, Shire PLC
Jon Symonds, Managing Director, Goldman Sachs International